{"version":"1.0","provider_name":"Newscoverage","provider_url":"https:\/\/newscoverage.org","title":"Laval firm trying to acquire Botox and Darpin through hostile take-over - Newscoverage","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"YiKietECN1\"><a href=\"https:\/\/newscoverage.org\/index.php\/2014\/06\/04\/laval-firm-trying-to-acquire-botox-and\/\">Laval firm trying to acquire Botox and Darpin through hostile take-over<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/newscoverage.org\/index.php\/2014\/06\/04\/laval-firm-trying-to-acquire-botox-and\/embed\/#?secret=YiKietECN1\" width=\"600\" height=\"338\" title=\"&#8220;Laval firm trying to acquire Botox and Darpin through hostile take-over&#8221; &#8212; Newscoverage\" data-secret=\"YiKietECN1\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/newscoverage.org\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"By Tracey Arialwww.thesuburban.com Laval-based pharmaceutical company Valeant lobbed a second volley in its hostile takeover attempt of Botox and Darpin maker Allergan last Wednesday. The dermatology and eye health specialist upped the cash portion of its offer to Allergan shareholders to $58.10 in cash plus 83 cents worth of Valeant shares for each dollar worth"}